Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,870 public trials 2,109 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)

NCT05085990

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +14 more
Locations
  • USC Norris Cancer Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Tulane Medical Center (TMC) - Clinic/Outpatient Facility New Orleans, Louisiana, United States
  • Chesapeake Urology Research Associates Baltimore, Maryland, United States
View Trial Details
Completed

Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)

NCT05085977

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +14 more
Locations
  • USC Norris Cancer Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Tulane Medical Center New Orleans, Louisiana, United States
  • Chesapeake Urology Research Associates Baltimore, Maryland, United States
View all 14 locations
View Trial Details
Completed

Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

NCT04524442

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +9 more
Locations
  • Istituto Europeo di Oncologia Milan, MI, Italy
  • Erasmus University Medical Center Rotterdam, Gelderland, Netherlands
  • Gammed-Centrum Diagnostyczno-Lecznicze Warsaw, Poland
  • University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
View Trial Details
Completed

Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab

NCT03674567

Conditions
Advanced Cancer, Breast Diseases, Breast Neoplasms, +44 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles JCCC Clinical Research Unit Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 35 locations
View Trial Details
Completed

Cabozantinib Treatment in a Phase II Study for Patients With Hepatocellular Carcinoma (HCC) Refractory to PD-1 Inhibitors

NCT04767906

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Technische Universität Dresden, Medizinische Fakultät Carl Gustav Carus Medizinische Klinik und Poliklinik I Dresden, Saxony, Germany
  • MVZ Mitte/MVZ Delitzsch GmbH Leipzig, Saxony, Germany
  • University Hospital Leipzig Leipzig, Saxony, Germany
  • Charite Universitätsmedizin, Campus Virchow Klinikum, Klinik für Hepatologie/Gastroenterologie Berlin, Germany
View Trial Details
Completed

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device

NCT06789224

Conditions
Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +74 more
Locations
  • Kliniken der Stadt Köln gGmbH Cologne, North Rhine-Westphalia, Germany
  • Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie Universitätsklinikum Frankfurt Frankfurt, Germany
  • Universitätsmedizin der Johannes Gutenberg-Universität Mainz Klinik für Anästhesiologie Mainz, Germany
  • Universitätsmedizin Mannheim, Klinik für Urologie und Urochirurgie Mannheim, Germany
View Trial Details

Related conditions